While medications like Ozempic and Wegovy are globally recognized for their impact on weight management and blood sugar regulation, a new conversation is emerging in the medical community: the potential effect of GLP-1 receptor agonists on skin health. Dermatologists are increasingly investigating how these drugs might address stubborn inflammatory conditions, though they warn that patient results can vary.

The Link Between GLP-1s and Psoriasis

Dr. Adam Friedman, a professor of dermatology at George Washington University, notes that psoriasis is fundamentally an immunometabolic disease. Because the immune system and metabolism interact in a constant feedback loop, the systemic changes brought on by GLP-1s may offer relief. “Anecdotally, I’ve noticed some of my psoriasis patients taking GLP-1s report fewer inflammatory flares and better control of their skin disease overall,” says Dr. Friedman.

Clinical data appears to support this. A 2026 study published in JAMA Dermatology observed that adults with psoriasis who used tirzepatide alongside biologics achieved complete skin clearance more frequently than those using biologics alone. Furthermore, research in the British Journal of Dermatology suggests these medications may lower the risk of severe cardiovascular events in psoriasis patients, who are already at a higher risk for heart disease.

Managing Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa, a chronic condition causing painful lumps in skin folds, is often notoriously difficult to treat. Recent pilot studies have shown promise: in one 2025 study, 80% of participants with HS saw significant symptom relief after six months of tirzepatide treatment. Experts emphasize that while these findings are intriguing, these drugs currently serve as an additional tool rather than a standalone cure for HS.

Is it Weight Loss or Anti-Inflammatory Effects?

Experts suggest that the skin benefits are likely a combination of both. Excess weight naturally increases friction and inflammation, which exacerbates conditions like psoriasis and HS. However, Dr. Steven Daveluy, a program director at Wayne State Dermatology, points out that the benefits may go beyond simple weight reduction: “In some psoriasis patients, skin improved before they lost significant weight,” suggesting a direct anti-inflammatory pathway at work.

Additional Skin Observations

Research is currently exploring other areas where GLP-1s might impact the skin:

  • Wound Healing: Preliminary animal studies suggest these drugs could activate tissue repair pathways, though human clinical trials are still required.
  • Acne: Observations indicate that improvements in acne may be linked to better metabolic health and lower insulin levels.
  • Eczema: Retrospective data indicates fewer flares among patients on GLP-1 therapy, likely due to reduced systemic inflammation.

Side Effects and Considerations

Not all skin-related effects are positive. The most frequently cited issue is hair shedding (telogen effluvium), often linked to rapid weight loss and nutritional deficiencies. Other side effects reported by the American Academy of Dermatology include:

  • Dry, itchy, or sensitive skin.
  • Injection-site reactions, such as redness or bruising.
  • The development of “Ozempic face,” where loss of facial volume leads to sagging or more prominent wrinkles.
  • Temporary skin tenderness or allodynia.

Ultimately, dermatologists urge a cautious approach. While these medications may be a viable option for patients struggling with both obesity and inflammatory skin disease, they are not yet an FDA-approved treatment for dermatological conditions. Patients are encouraged to consult with their healthcare providers to determine if the benefits outweigh the risks based on their personal medical history.